Response to bortezomib therapy for multiple myeloma (MM) in actual clinical practice: Preliminary effectiveness findings of an international observational study

被引：0
|
作者：
Delforge, Michel [1 ]
Katodritou, Eirini [2 ]
Zervas, Konstantinos [2 ]
Sargin, Deniz [3 ]
Hulin, Cyrille [4 ]
Linderholm, Mats [5 ]
Verrou, Evgenia [2 ]
Poon, Vicki [6 ]
Dhawan, Ravinder [6 ]
机构：
[1] Univ Hosp Leuven, Dept Hematol, Louvain, Belgium
[2] Theagenion Canc Ctr, Dept Hematol, Thessaloniki, Greece
[3] Istanbul Univ, Dept Internal Med, Div Hematol, Istanbul, Turkey
[4] Univ Nancy Brabois, Ctr Hosp, Vandoeuvre Les Nancy, France
[5] Linkoping Univ Hosp, Dept Haematol, S-58185 Linkoping, Sweden
[6] Johnson & Johnson, Raritan, NJ USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4837.4837
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4837
引用
收藏
页码：284B / 284B
页数：1
相关论文
共 50 条
  • [41] Outcomes of Post-Induction Bortezomib Therapy in Patients with Newly diagnosed Multiple Myeloma: A Multi-Center Retrospective Observational Study
    Luttwak, Efrat
    Gatt, Moshe
    Lavi, Noa
    Tadmor, Tamar
    Kreiniz, Natalia
    Benyamini, Noam
    Horowitz, Netanel
    Suriu, Celia
    Avivi, Irit
    Trestman, Svetlana
    Mittelman, Moshe
    Ram, Ron
    Rouvio, Ory
    Cohen, Yael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E296 - E296
  • [42] Bortezomib, doxorubicin and dexamethasone (PAD) combination therapy followed by thalidomide and dexamethasone (TD) as a salvage treatment for relapsed multiple myeloma (MM): Preliminary analysis of efficacy and safety
    Lee, J. H.
    Suh, C.
    Lee, S. S.
    Kim, B. S.
    Chung, J. S.
    Joo, Y. D.
    Ryoo, H. M.
    Do, Y. R.
    Jin, J. Y.
    Kang, H. J.
    Lee, K. W.
    Lee, M. H.
    Shim, H.
    Kim, K.
    Yoon, S. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 163 - 163
  • [43] Bortezomib, doxorubicin and dexamethasone (PAD) combination therapy followed by thalidomide and dexamethasone (TD) as a salvage treatment for relapsed multiple myeloma (MM): Preliminary analysis of efficacy and safety
    Lee, Sung Sook
    Suh, Cheolwon
    Kim, Bong-Seog
    Chung, Jooseop
    Joo, Young-Don
    Ryoo, Hun-Mo
    Do, Young Rok
    Jin, Jong-Youl
    Kang, Hye Jin
    Lee, Gyeong-Won
    Lee, Moon Hee
    Shim, Hyeok
    Kim, Kihyun
    Yoon, Sung Soo
    Kim, Ho Young
    Lee, Dong Soon
    Lee, Jae-Hoon
    BLOOD, 2007, 110 (11) : 802A - 802A
  • [44] PROLONGED THERAPY WITH BORTEZOMIB PLUS MELPHALAN-PREDNISONE (VMP) RESULTS IN IMPROVED QUALITY AND DURATION OF RESPONSE IN THE PHASE III VISTA STUDY IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA (MM)
    Palumbo, A.
    Schlag, R.
    Khuageva, N.
    Shpilberg, O.
    Dimopoulos, M.
    Kropff, M.
    Spicka, I.
    Petrucci, M.
    Delforge, M.
    Mateos, M.
    Esseltine, D.
    Liu, K.
    Deraedt, W.
    Van de Velde, H.
    Richardson, P.
    San-Miguel, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 83 - 83
  • [45] CLINICAL BENEFIT OF BORTEZOMIB I IMIDS IN PATIENTS OVER 75 YEARS WITH MULTIPLE MYELOMA IN HABITUAL CLINICAL PRACTICE. RESTROPECTIVE AND UNICENTRIC STUDY
    Gonzalez, Y.
    Cruz, D.
    Moret, C.
    Osca, G.
    Tuset, E.
    Gallardo
    HAEMATOLOGICA, 2018, 103 : 112 - 113
  • [46] Lenalidomide, Bortezomib, and Dexamethasone (RVD) in Combination with Vorinostat As Front-Line Therapy for Patients with Multiple Myeloma (MM): Results of a Phase 1 Study
    Kaufman, Jonathan L.
    Shah, Jatin J.
    Laubach, Jacob P.
    Mitchell, Alaina R.
    Sharp, Cathy
    Lewis, Colleen
    Harvey, R. Donald
    Gleason, Charise
    Casbourne, Daniela
    Nooka, Ajay K.
    Heffner, Leonard T.
    Richardson, Paul G.
    Orlowski, Robert Z.
    Lonial, Sagar
    BLOOD, 2012, 120 (21)
  • [47] Effectiveness, tolerability and safety of a long-term therapy with levomethadone in clinical practice: A retrospective observational study
    Consoli, Augusto
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2021, 23 (04) : 33 - 41
  • [48] The effect of steroid pulse therapy on carbohydrate metabolism in multiple myeloma patients: a randomized crossover observational clinical study
    Veber, O.
    Wilde, A.
    Demeter, J.
    Tamas, G.
    Mucsi, I.
    Tabak, A. G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (04): : 345 - 351
  • [49] The effect of steroid pulse therapy on carbohydrate metabolism in multiple myeloma patients: a randomized crossover observational clinical study
    O. Véber
    A. Wilde
    J. Demeter
    G. Tamás
    I. Mucsi
    A. G. Tabák
    Journal of Endocrinological Investigation, 2014, 37 : 345 - 351
  • [50] A phase II clinical study of arsenic trioxide (ATO) in patients(pts) with relapsed or refractory multiple myeloma (MM); a preliminary report
    Hussein, MA
    Mason, J
    Ravandi, F
    Rifkin, RM
    BLOOD, 2001, 98 (11) : 378A - 378A
12345